While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 7.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$167 Million to the region's size and clout in the next 5 to 6 years. Over US$319 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Single-Chamber will reach a market size of US$231 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.2% over the next couple of years and add approximately US$1.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others, Baxter International, Inc. (USA); Becton, Dickinson and Company (USA); Gerresheimer AG (Germany); Medtronic PLC (Ireland); SCHOTT AG (Germany); Stevanato Group Company (USA); Terumo Corporation (Japan); Unilife Corporation (USA); Vetter Pharma International GmbH (Germany); West Pharmaceutical Services, Inc. (USA)